Table 1:

Patient demographic and clinical information

SubjectAge (yr), SexPrimary Tumor (grade)RT Type, Dose, Timing (completed prior to imaging)Steroids at Imaging
A31, MAA (III)60-Gy 3D conformal (9 mo)Yes
25-Gy salvage IMRT (2 mo)
B58, MGBM (IV)54-Gy 3D conformal (22 mo)Yes
12-Gy gamma knife (5 mo)
C36, MGBM (IV)60-Gy IMRT (3 mo)None
D56, MGBM (IV)60-Gy IMRT (23 mo)Yes
30-Gy IMRT (10 mo)
E45, FGBM (IV)60-Gy 3D conformal (26 mo)None
FaExcluded due to motion
G50, MGBM (IV)37.5-Gy whole brain RT (8 mo)Yes
30-Gy IMRT (5 mo)
Hb38, MAna. GG (III)59.4-Gy IMRT (28.5 mo)Yes
12-Gy gamma knife (15.5 mo)
I59, MGBM (IV)59.4-Gy IMRT (13 mo)None
JaExcluded due to motion
K62, MGBM (IV)54-Gy 3D conformal (12 mo)None
Lb38, MAna. GG (III)54-Gy IMRT (24 months)None
12-Gy gamma knife (11 mo)
M43, MGBM (IV)60-Gy 3D conformal (8 mo)Yes
10-Gy gamma knife (7 mo)
  • Note:—RT indicates radiation therapy; AA, anaplastic astrocytoma; GBM, glioblastoma multiforme; Ana. GG, anaplastic ganglioglioma; IMRT, intensity modulated radiation therapy.

  • a Excluded from analysis due to motion during scanning.

  • b A single patient who underwent 2 separate surgeries 4.5 months apart.